Dr. Koletsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6282 Linton Blvd
Delray Beach, FL 33484Phone+1 561-495-8307Fax+1 561-495-6422
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
- University of Vermont Medical CenterResidency, Internal Medicine, 1980 - 1983
- Case Western Reserve University School of MedicineClass of 1980
Certifications & Licensure
- FL State Medical License 1989 - 2026
- MA State Medical License 1986 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Gulfstream FL-Palm Beach Castle Connolly, 2007-2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
- Top Doctors: Florida Castle Connolly, 2000
- Join now to see all
Clinical Trials
- A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 58 citationsAndrogen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate CancerBruce Montgomery, Mario A. Eisenberger, Matthew Rettig, Franklin Chu, Roberto Pili
Clinical Cancer Research. 2016-03-15 - 8 citationsDocetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.Mohammad Jahanzeb, Greg Sarna, Robert Hirsch, Peter Radice, Alan J. Koletsky
Anticancer Research. 2004-03-01 - 17 citationsPhase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer.Alan J. Koletsky, Manuel L. Guerra, L. Kronish
Cancer Journal. 2003-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: